<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Using middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) and in vivo microdialysis, we have evaluated the changes in extracellular concentrations of the excitatory amino acids (EAA) <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> and <z:chebi fb="0" ids="29995">aspartate</z:chebi> during varying periods of MCAO (0, 30, 60 min) in the striatum of spontaneously hypertensive rats (SHR) </plain></SENT>
<SENT sid="1" pm="."><plain>A positive correlation between occlusion time-dependent elevations in EAAs and the resulting ischemic injury was observed </plain></SENT>
<SENT sid="2" pm="."><plain>This is the first demonstration of the temporal profile of EAA efflux during transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in SHRs </plain></SENT>
<SENT sid="3" pm="."><plain>Possible sources and mechanisms of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced EAA efflux were examined during 60 min of MCAO </plain></SENT>
<SENT sid="4" pm="."><plain>Removal of Ca(2+) from the microdialysis infusion media significantly attenuated <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced increases in both <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> (from ischemic peak of 4892 +/- 1298 to 1144 +/- 666% of preischemic values) and <z:chebi fb="0" ids="29995">aspartate</z:chebi> (from 2703 +/- 682 to 2090 +/- 599% of preischemic values) </plain></SENT>
<SENT sid="5" pm="."><plain>Similarly, infusion of the voltage dependent <z:chebi fb="0" ids="29101">Na(+)</z:chebi> channel blocker <z:chebi fb="2" ids="9506">tetrodotoxin</z:chebi> (<z:chebi fb="0" ids="9506">TTX</z:chebi>; 10 microM) significantly attenuated MCAO-induced increases in <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> (to 1313 +/- 648%) and <z:chebi fb="0" ids="29995">aspartate</z:chebi> (to 359 +/- 114%) </plain></SENT>
<SENT sid="6" pm="."><plain>Infusion of the GLT-1 selective nontransportable inhibitor, dihydrokainate (DHK; 1 mM) also significantly attenuated the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced increases in both EAAs (1285 +/- 508 and 1366 +/- 741% of the preischemic levels, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>These results indicate that during transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> the increase in extracellular EAAs originates from both the neuronal pool, via conventional exocytotic release, and glial sources via the reversal of the GLT-1 transporter </plain></SENT>
</text></document>